{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:58:19Z","timestamp":1793444299660,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1213\/ane.0b013e3181e13470","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T10:53:32Z","timestamp":1275476012000},"page":"173-179","source":"Crossref","is-referenced-by-count":51,"title":["Correlations Between Activated Clotting Time Values and Heparin Concentration Measurements in Young Infants Undergoing Cardiopulmonary Bypass"],"prefix":"10.1213","volume":"111","author":[{"given":"Nina A.","family":"Guzzetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather G.","family":"Monitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet D.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.","family":"Fazlollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20210902","first-page":"161","article-title":"Mechanism of action and monitoring anticoagulants. Semin Thromb Hemost 1986;12:1-11 vs Bjork I, Lindahl U. Mechanism of the anticoagulant action of heparin.","volume":"48","author":"Hirsh","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"R2-30-20210902","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0038-1649703","article-title":"Heparin therapy during cardiopulmonary bypass in children requires ongoing quality control.","volume":"70","author":"Andrew","year":"1993","journal-title":"Thromb Haemost"},{"key":"R3-30-20210902","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1051\/ject\/1980126139","article-title":"Activated clotting times and cardiopulmonary bypass I: The effect of hemodilution and hypothermia upon activated clotting time.","volume":"12","author":"Cohen","year":"1980","journal-title":"J Extra Corporeal Technol"},{"key":"R4-30-20210902","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0038-1650684","article-title":"More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.","volume":"76","author":"Despotis","year":"1996","journal-title":"Thromb Haemost"},{"key":"R5-30-20210902","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00000542-200210000-00014","article-title":"Hemostatic activation and inflammatory response during cardiopulmonary bypass.","volume":"97","author":"Koster","year":"2002","journal-title":"Anesthesiology"},{"key":"R6-30-20210902","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0003-4975(00)02586-8","article-title":"Individualized heparin and protamine management in infants and children undergoing cardiac operations.","volume":"71","author":"Codispoti","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R7-30-20210902","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1213\/01.ane.0000297290.03501.db","article-title":"A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.","volume":"106","author":"Guzzetta","year":"2008","journal-title":"Anesth Analg"},{"key":"R8-30-20210902","first-page":"298","article-title":"Plasma heparin: a unique, practical, submicrogram-sensitive assay.","volume":"81","author":"Yin","year":"1973","journal-title":"J Lab Clin Med"},{"key":"R9-30-20210902","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-5223(94)70150-4","article-title":"Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.","volume":"108","author":"Despotis","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R10-30-20210902","first-page":"645","article-title":"Real time measurement of heparin concentration during cardiopulmonary bypass.","volume":"40","author":"Hashimoto","year":"1999","journal-title":"J Cardiovasc Surg"},{"key":"R11-30-20210902","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1191\/0267659103pf672oa","article-title":"Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time.","volume":"18","author":"Raymond","year":"2003","journal-title":"Perfusion"},{"key":"R12-30-20210902","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/026765910001500304","article-title":"Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass.","volume":"15","author":"Gruenwald","year":"2000","journal-title":"Perfusion"},{"key":"R14-30-20210902","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00000542-199910000-00031","article-title":"Anticoagulation monitoring during cardiac surgery. A review of current and emerging techniques.","volume":"91","author":"Despotis","year":"1999","journal-title":"Anesthesiology"},{"key":"R16-30-20210902","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility.","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"R17-30-20210902","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R18-30-20210902","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2257.1999.00183.x","article-title":"Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin dalteparin or unfractionated heparin.","volume":"21","author":"Kovacs","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"R20-30-20210902","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0003-4975(94)90752-8","article-title":"Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.","volume":"58","author":"Hashimoto","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R21-30-20210902","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/mtc.2002.119060","article-title":"Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.","volume":"123","author":"Lemmer","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-30-20210902","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","article-title":"Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.","volume":"130","author":"Avidan","year":"2005","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201007000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:16:59Z","timestamp":1786112219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201007000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181e13470","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4584957.4457055","asserted-by":"object"}]},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}